+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Biological Product Market by Product Type (Antitoxins, Diagnostics, Vaccines), Animal Type (Aquaculture, Companion Animals, Livestock), Route of Administration, End User, Disease Indication - Global Forecast 2025-2030- Product Image
Veterinary Biological Product Market by Product Type (Antitoxins, Diagnostics, Vaccines), Animal Type (Aquaculture, Companion Animals, Livestock), Route of Administration, End User, Disease Indication - Global Forecast 2025-2030- Product Image
Sale

Veterinary Biological Product Market by Product Type (Antitoxins, Diagnostics, Vaccines), Animal Type (Aquaculture, Companion Animals, Livestock), Route of Administration, End User, Disease Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6146635
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The veterinary biological products industry stands at an inflection point where innovation and evolving disease pressures converge to redefine animal health management. A surge in companion animal ownership, intensified aquaculture operations, expanding livestock farming, and stringent government mandates on biosecurity have collectively reshaped demand dynamics for antitoxins, diagnostics, and vaccines. Simultaneously, global supply chain complexities and changing regulatory landscapes are driving stakeholders to adopt more agile and technology-enabled approaches.

Against this backdrop, the executive summary synthesizes critical trends and insights that will inform strategic decision-making. From paradigm-shifting technological innovations to the ramifications of new tariff schedules, each component of this summary illuminates the drivers, challenges, and opportunities shaping the market’s trajectory. By exploring segmentation nuances, regional disparities, key players’ positioning, and actionable recommendations, industry leaders will gain a holistic perspective to chart sustainable growth paths and competitive differentiation in the veterinary biological arena.

Witness the Emergence of Precision Prevention and Digital Diagnostics Revolutionizing Animal Disease Management Paradigms

The past decade has witnessed transformative shifts in the veterinary biological product landscape, propelled by technological advancements, digital integration, and a heightened emphasis on preventive care. Rapid progress in recombinant vaccine platforms and adjuvant technologies has accelerated the development cycle, enabling more targeted immunization strategies for both livestock and companion animals. Concurrently, digital diagnostics-powered by artificial intelligence and mobile health applications-have streamlined disease detection, facilitating on-farm monitoring and real-time outbreak responses.

Moreover, heightened consumer awareness around animal welfare and antimicrobial stewardship has sparked a move away from broad-spectrum therapeutics toward precision interventions. Integrated data platforms now allow producers and veterinarians to optimize vaccination schedules and dosage regimens based on real-time epidemiological intelligence. As a result, the industry is transitioning from reactive treatment models to proactive health management frameworks, underscoring a fundamental shift in how biological products are developed, regulated, and deployed.

Explore How 2025 Tariff Adjustments Are Redefining Production Costs and Supply Chain Strategies in the U.S. Veterinary Biologics Market

New tariff policies enacted in 2025 have introduced a significant variable in the United States veterinary biological product ecosystem, altering import-export equilibria and cost structures. By increasing duties on select antitoxins and diagnostic kits, regulatory authorities intend to bolster domestic manufacturing capabilities and protect strategic supply chains. However, these measures have also elevated production costs and extended time-to-market for certain imported reagents and vaccine components.

Domestic producers are now reevaluating sourcing strategies, forging partnerships to localize critical raw materials and expand in-house formulation capacities. At the same time, parallel trade flows have emerged to circumvent higher duties, creating complexity in compliance and quality assurance. The net effect of these tariff adjustments has been a recalibration of competitive dynamics, compelling multinational corporations to emphasize regional manufacturing footprints and leverage economies of scale, while smaller enterprises focus on niche, high-value therapeutic segments to preserve margins.

Unearth Critical Multi-Dimensional Segmentation Dynamics That Illuminate Opportunities Across Product, Species, Administration Route, End User, and Disease Indication

Insight into the sector’s segmentation reveals nuanced opportunities and risk profiles across multiple axes of market analysis. The product portfolio spans antitoxins designed to neutralize specific bacterial toxins, diagnostics that employ molecular assays and immunoassays for rapid disease detection, and advanced vaccines engineered to confer broad-spectrum immunity. Each category demands distinct investment in R&D, regulatory compliance pathways, and scale-up capacities.

By animal type, the market segments into aquaculture operations that require water-stable vaccine formulations, companion animal offerings tailored to the unique immunological needs of canine, equine, and feline patients, and livestock solutions addressing bovine, caprine, ovine, and porcine health. Delivery modalities vary from injection routes-including intramuscular, intravenous, and subcutaneous options-to non-invasive nasal sprays and oral immunotherapies. End-user channels range from clinics and veterinary hospitals to farm-based administrations and government-led mass vaccination campaigns. Disease indication further refines the landscape: targeting bacterial threats such as anthrax, brucellosis, and salmonellosis; parasitic challenges; and viral diseases like foot and mouth disease, Newcastle disease, and rabies. Understanding these layers of segmentation is essential for stakeholders to allocate resources effectively and tailor go-to-market approaches.

Delve into Regional Nuances from the Americas to EMEA and Asia-Pacific That Drive Tailored Strategies for Veterinary Biological Products

Regional performance in the veterinary biological sphere is defined by diverse regulatory regimes, epidemiological profiles, and resource endowments. In the Americas, robust infrastructure and significant investment in companion animal wellness have catalyzed demand for premium diagnostics and recombinant vaccines. At the same time, emerging export markets in Latin America are expanding livestock immunization programs to combat endemic diseases and improve food security.

Across Europe, the Middle East, and Africa, stringent safety standards and centralized procurement systems shape a landscape where compliance costs and distribution logistics are pivotal. Government-backed initiatives to eradicate zoonotic diseases have fueled large-scale immunization drives, and public-private partnerships are accelerating rollout of novel biologics. Meanwhile, Asia-Pacific markets are characterized by rapid aquaculture expansion and surging pet ownership, driving innovation in thermostable vaccine formulations and point-of-care testing technologies. Local manufacturing collaborations and technology transfer agreements are key strategies to meet diverse regional needs.

Uncover How Leading Corporations and Agile Biotech Innovators Are Competing Through R&D Integration, Strategic Partnerships, and Novel Delivery Platforms

Leading industry players demonstrate divergent strategies to secure competitive advantage. Established multinational corporations leverage integrated R&D pipelines and global distribution networks to drive scale in vaccine production and diagnostic kit manufacturing. Their portfolios often encompass next-generation adjuvants, recombinant vector vaccines, and multiplexed assay platforms. These organizations also invest heavily in intellectual property protection and regulatory affairs teams to expedite approvals across jurisdictions.

At the same time, a cadre of agile biotech innovators is disrupting the market with specialized formulations, rapid assay development, and modular vaccine manufacturing platforms. Partnerships between academic institutions and small-to-medium enterprises are yielding breakthrough delivery systems, including nanoenabled carriers and thermostable compounds that reduce cold-chain dependency. These ventures often capitalize on government grants and disease eradication programs to validate efficacy and secure initial market entry, before scaling via contract manufacturing organizations.

Implement Strategic Investments in Local Manufacturing, Digital Diagnostics, Collaborative R&D, and Regulatory Advisory Frameworks to Future-Proof Growth

Industry leaders should pursue a multifaceted approach to secure long-term growth and resilience. First, expanding in-region manufacturing capabilities through strategic joint ventures or greenfield investments will mitigate tariff impacts and supply chain disruptions. Simultaneously, ramping up digital diagnostics integration with cloud-based monitoring systems can enhance service offerings and differentiate product portfolios.

In parallel, organizations must prioritize partnership frameworks with academic institutions and startup incubators to access cutting-edge vaccine platforms and adjuvant technologies. Investing in modular manufacturing will enable rapid scale-up during disease outbreaks, while fundraising for collaborative R&D can preempt emerging zoonotic threats. Finally, establishing advisory councils with veterinary practitioners and regulatory experts will ensure that product development aligns with evolving safety standards and market needs.

Discover How Comprehensive Primary Interviews, Secondary Data Synthesis, and Advanced Modeling Techniques Deliver Robust Insights into Veterinary Biologics Trends

Our research methodology integrates a blend of primary interviews, secondary data assimilation, and advanced analytical techniques to ensure rigor and relevance. Primary research involved structured interviews with veterinarians, industry executives, and government officials across major markets. These insights were corroborated by field observations at livestock and aquaculture facilities, providing real-world context to laboratory innovations.

Secondary data sources included peer-reviewed journals, regulatory filings, and epidemiological databases to map disease prevalence trends. Trade reports and customs data informed our understanding of tariff impacts and cross-border flows. Quantitative models were then developed to analyze segment-specific cost drivers, distribution channel efficiencies, and adoption curves for novel biologics. The findings were subjected to validation workshops with domain experts to refine assumptions and ensure actionable precision.

Synthesize the Path Forward Where Innovation, Collaboration, and Resilience Converge to Define Leadership in Animal Health Solutions

The veterinary biological products market is poised for accelerated transformation driven by technological breakthroughs, shifting regulatory frameworks, and evolving disease landscapes. Stakeholders who align their strategies with precision prevention, digital integration, and resilient supply chain architectures will emerge as victors in this dynamic environment. Navigating the interplay of segmentation nuances and regional intricacies is vital to unlocking targeted growth avenues.

As tariff regimes evolve and novel threats emerge, the ability to pivot quickly and deploy scalable manufacturing solutions will determine market leadership. By synthesizing cutting-edge R&D, collaborative partnerships, and data-driven decision-making, organizations can harness the full potential of antitoxins, diagnostics, and vaccines to safeguard animal health and drive sustainable profitability. The journey ahead demands both visionary thinking and pragmatic execution to meet the twin imperatives of innovation and resilience.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Antitoxins
    • Diagnostics
    • Vaccines
  • Animal Type
    • Aquaculture
    • Companion Animals
      • Canine
      • Equine
      • Feline
    • Livestock
      • Bovine
      • Caprine
      • Ovine
      • Porcine
    • Poultry
  • Route Of Administration
    • Injection
      • Intramuscular
      • Intravenous
      • Subcutaneous
    • Nasal
    • Oral
  • End User
    • Clinics
    • Farmers
    • Government Agencies
    • Veterinary Hospitals
  • Disease Indication
    • Bacterial Diseases
      • Anthrax
      • Brucellosis
      • Salmonellosis
    • Parasitic Diseases
    • Viral Diseases
      • Foot And Mouth Disease
      • Newcastle Disease
      • Rabies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SA
  • Virbac SA
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • IDT Biologika GmbH

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of mRNA-based vaccines for rapid response to emerging zoonotic diseases
5.2. Increasing integration of AI-driven diagnostics in monitoring vaccine efficacy in livestock populations
5.3. Rising investment in recombinant protein-based biologics for companion animal immunotherapies
5.4. Development of universal multivalent vaccines to address multiple livestock pathogens simultaneously
5.5. Expansion of refrigerated cold chain infrastructure to support distribution of temperature-sensitive biologics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Veterinary Biological Product Market, by Product Type
8.1. Introduction
8.2. Antitoxins
8.3. Diagnostics
8.4. Vaccines
9. Veterinary Biological Product Market, by Animal Type
9.1. Introduction
9.2. Aquaculture
9.3. Companion Animals
9.3.1. Canine
9.3.2. Equine
9.3.3. Feline
9.4. Livestock
9.4.1. Bovine
9.4.2. Caprine
9.4.3. Ovine
9.4.4. Porcine
9.5. Poultry
10. Veterinary Biological Product Market, by Route Of Administration
10.1. Introduction
10.2. Injection
10.2.1. Intramuscular
10.2.2. Intravenous
10.2.3. Subcutaneous
10.3. Nasal
10.4. Oral
11. Veterinary Biological Product Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Farmers
11.4. Government Agencies
11.5. Veterinary Hospitals
12. Veterinary Biological Product Market, by Disease Indication
12.1. Introduction
12.2. Bacterial Diseases
12.2.1. Anthrax
12.2.2. Brucellosis
12.2.3. Salmonellosis
12.3. Parasitic Diseases
12.4. Viral Diseases
12.4.1. Foot And Mouth Disease
12.4.2. Newcastle Disease
12.4.3. Rabies
13. Americas Veterinary Biological Product Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Veterinary Biological Product Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Veterinary Biological Product Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Zoetis Inc.
16.3.2. Boehringer Ingelheim Animal Health GmbH
16.3.3. Merck & Co., Inc.
16.3.4. Elanco Animal Health Incorporated
16.3.5. Ceva Santé Animale SA
16.3.6. Virbac SA
16.3.7. Vetoquinol SA
16.3.8. Phibro Animal Health Corporation
16.3.9. Dechra Pharmaceuticals PLC
16.3.10. IDT Biologika GmbH
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. VETERINARY BIOLOGICAL PRODUCT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VETERINARY BIOLOGICAL PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VETERINARY BIOLOGICAL PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VETERINARY BIOLOGICAL PRODUCT MARKET: RESEARCHAI
FIGURE 26. VETERINARY BIOLOGICAL PRODUCT MARKET: RESEARCHSTATISTICS
FIGURE 27. VETERINARY BIOLOGICAL PRODUCT MARKET: RESEARCHCONTACTS
FIGURE 28. VETERINARY BIOLOGICAL PRODUCT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VETERINARY BIOLOGICAL PRODUCT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANTITOXINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANTITOXINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY AQUACULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY CANINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY CANINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY FELINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY FELINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BOVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BOVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY CAPRINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY CAPRINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY OVINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY OVINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PORCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PORCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY POULTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY FARMERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY FARMERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANTHRAX, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANTHRAX, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BRUCELLOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BRUCELLOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY SALMONELLOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PARASITIC DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY FOOT AND MOUTH DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY FOOT AND MOUTH DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY NEWCASTLE DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY RABIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY RABIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 140. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 141. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 142. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 143. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 144. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 145. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 146. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 147. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 148. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 149. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 150. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 151. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 156. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 157. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 158. CANADA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 159. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 162. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 163. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 166. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 167. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 170. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 171. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 176. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 177. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 178. MEXICO VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 261. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 264. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 265. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 268. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 269. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 272. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 273. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 274. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 275. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 276. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 277. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 278. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 279. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 280. GERMANY VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 281. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 282. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 283. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 284. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 285. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
TABLE 288. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY LIVESTOCK, 2025-2030 (USD MILLION)
TABLE 289. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2018-2024 (USD MILLION)
TABLE 292. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY INJECTION, 2025-2030 (USD MILLION)
TABLE 293. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2018-2024 (USD MILLION)
TABLE 296. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY DISEASE INDICATION, 2025-2030 (USD MILLION)
TABLE 297. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2018-2024 (USD MILLION)
TABLE 298. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY BACTERIAL DISEASES, 2025-2030 (USD MILLION)
TABLE 299. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2018-2024 (USD MILLION)
TABLE 300. FRANCE VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY VIRAL DISEASES, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA VETERINARY BIOLOGICAL PRODUCT MARKET SIZE,

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Veterinary Biological Product market report include:
  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Ceva Santé Animale SA
  • Virbac SA
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Dechra Pharmaceuticals PLC
  • IDT Biologika GmbH

Related Topics

Related Reports

Veterinary API Market Size, Share & Industry Trends Analysis Report By Route of Administration, By API Type, By Synthesis Type, By Animal Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Veterinary API Market Size, Share & Industry Trends Analysis Report By Route of Administration, By API Type, By Synthesis Type, By Animal Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 294 Pages
  • Global
From
Animal Health Market Report 2025-2033 - Product Image

Animal Health Market Report 2025-2033

  • Report
  • 130 Pages
  • Global
From
Europe Veterinary API Market Size, Share & Industry Trends Analysis Report By Route of Administration, By API Type, By Synthesis Type, By Animal Type, By Country and Growth Forecast, 2023 - 2030 - Product Image

Europe Veterinary API Market Size, Share & Industry Trends Analysis Report By Route of Administration, By API Type, By Synthesis Type, By Animal Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • 137 Pages
  • Europe
From
Veterinary Service Market Report by Service, Animal Type, End Use, and Region 2025-2033 - Product Image

Veterinary Service Market Report by Service, Animal Type, End Use, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Forecast to 2028 - Product Image

Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Forecast to 2028

  • Report
  • 272 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.